NCT06933095View on ClinicalTrials.gov

Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia

NARecruitingINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

September 15, 2029

Study Completion Date

September 15, 2029

Conditions
Eldery PeopleCognitive DeclineMemory DeclineDHA CNS Delivery
Interventions
DIETARY_SUPPLEMENT

LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta)

apsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta)

Trial Locations (1)

45219

RECRUITING

University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER